Search

Now showing items 1-10 of 113

Efficacy of Agomelatine 25-50mg in Major Depressive Disorder.

Kennedy S; Oli?? JP; Loo H; Emsley RA (2006)

First-line Treatment with Long-acting Risperidone in Subjects with First-Episode Psychosis: Safety and Efficacy Results from a 6-month Interim Analysis.

Emsley RA; Oosthuizen P; Koen L; Niehaus DJH; Medori R (2006)

Functional Recovery in Subjects with First-Episode Psychosis Treated with Long-Acting Resperidone as First-line Treatment: 6-Month Interim Analyses.

Medori R; Oosthuizen P; Koen L; Niehaus DJH; Emsley RA (2006)

The importance of relapse prevention in schizophrenia

Emsley RA (2010)

The true cost of non-adherence in schizophrenia

Emsley RA (Mind & Brain, The Journal of Psychiatry, 2010)

Physician awareness of partial and non-adherence to antipsychotic medication in schizophrenia: results from a survey conducted across Europe, the Middle East and Africa

Emsley RA; Alptekin K; Canas F; Gorwood P; Naber D; Olivares JM; Roca M; Martinez G; Schreiner A; Hargarter L (2010)

The Relationships Between Depression and Remission in First-episode Psychosis.

Oosthuizen P; Emsley RA; Niehaus DJH; Koen L; Chiliza B (World Psychiatry, 2006)

Treatment of first-episode psychosis: Efficacy and tolerability of a long-acting typical antipsychotic

Chiliza B; Schoeman R; Emsley RA; Oosthuizen PP; Koen L; Niehaus DJH; Hawkridge SM (2008)

Treating schizophrenia: Have we got it wrong

Emsley RA (2008)

Safety and efficacy of long-term asenapine versus olanzapine in schizophrenia or schizoaffective disorder patients

Schoemaker J; Naber D; Jansen W; Panagides J; Emsley RA (2010)

1
2
3
4
. . .
12